Switzer TV

Switzer Investing TV | 12 May 2025

Jun Bei Liu talks us through some rare stock picks and talks the potential US-China trade deal, we walk through the charts and talk WBC, MQG and BHP, and ask a bullion expert: why is Gen Z suddenly buying gold?

More videos

Reddit/GameStop! Local shorted stocks that our experts like: WEB, A2M & ING!

Adam Dawes from Shaw and Partners, Paul Rickard from Switzer and Julia Lee from Burman Invest join Peter Switzer.

Series:
It’s not too late to quit smoking

Dr Ross Walker discusses the negative effects of smoking on your health and how they markedly reduce once you stop smoking.

Series:
Stocks fund managers like: Nuix, Sezzle, Redbubble, Lynas and Telstra!!

In this week's show, Peter Switzer speaks to Jun Bei Liu, Julia Lee, Paul Rickard and Michael Terpin.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for the latest money news in a new live episode of Mad about Money!

Series:
Peter Cook from Novatti Group (ASX:NOV)

Peter Switzer sits down with the CEO of Novatti (NOV), Peter Cook.

Series:
Another new treatment for Glioblastoma

Dr Ross Walker talks about another new trial into treating Glioblastoma, one of the most aggressive brain cancers.

Series:
Will HospoKeeper replace JobKeeper?

Peter Switzer and Paul Rickard look at the potential replacements to JobKeeper, why Wall Street likes Joe Biden and what JB Hi-Fi's strong sales numbers mean for the economy.

Series:
Dr Chris Hart from Oventus Medical (ASX:OVN)

Peter Switzer speaks to the founder and CEO of Oventus (OVN), Dr Chris Hart.

Series:
BUY or SELL these hot stocks: Tyro, Z1P, A2M, ELO, EML, TWE, NXT and MP1

On this week's show, Peter Switzer is joined by Fairmont Equities' Michael Gable, Burman Invest's Julia Lee, Switzer's Paul Rickard and Avecho's Dr Paul Gavin.

Series:
Brian Ward from Aroa Biosurgery (ASX:ARX)

Peter Switzer is joined by Brian Ward, the founder and CEO of soft tissue regeneration company Aroa (ARX).

Series:
Two new treatments for Glioblastoma

Dr Ross Walker explains two studies that are finding new treatments for Glioblastoma, one of the most devastating kinds of brain tumour.

Series:
Peter Switzer & Paul Rickard look at the stocks they like for 2021

Peter and Paul take a look back on 2020 and look ahead to the stocks that will do well in 2021, plus highlights from an interview with technology entrepreneur Bevan Slattery.

Series:
1 35 36 37 38 39 50

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram